These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 11559975)
1. Closing in on cancer. O'Keefe B Fortune; 2001 Sep; 144(5):222. PubMed ID: 11559975 [No Abstract] [Full Text] [Related]
2. The difficulties industry is facing with investigators. Blackledge GR Eur J Cancer; 2005 Oct; 41(15):2210-2. PubMed ID: 16214043 [TBL] [Abstract][Full Text] [Related]
9. Are the large pharmaceutical and biotechnology companies driving the discovery, research and development of targeted cancer therapies? Gallant GJ Future Med Chem; 2012 Jan; 4(1):13-7. PubMed ID: 22168161 [No Abstract] [Full Text] [Related]
10. Business barriers slowing the pace of cancer immunotherapy research and development. Tuma RS J Natl Cancer Inst; 2007 Nov; 99(21):1570-3. PubMed ID: 17971521 [No Abstract] [Full Text] [Related]
12. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy. Tear S; Zarkowska T IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303 [No Abstract] [Full Text] [Related]
13. The role of the National Cancer Institute in drug development. Doroshow J Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997 [No Abstract] [Full Text] [Related]
14. This Dutchman is flying. Watson N Fortune; 2003 Jun; 147(13):89-90. PubMed ID: 12827720 [No Abstract] [Full Text] [Related]
15. Therapeutic cancer vaccines on trial. Reichert JM; Paquette C Nat Biotechnol; 2002 Jul; 20(7):659-63. PubMed ID: 12089545 [No Abstract] [Full Text] [Related]
16. A very firm handshake: biotech's growing negotiating power. Thiel KA Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058 [No Abstract] [Full Text] [Related]
17. Trials and error. Jacobs T Nat Biotechnol; 2005 Dec; 23(12):1481. PubMed ID: 16333284 [No Abstract] [Full Text] [Related]